Construction and Validation of a Diagnostic Scoring System for Predicting Active Pulmonary Tuberculosis in Patients with Positive T-SPOT Based on Indicators Associated with Coagulation and Inflammation: A Retrospective Cross-Sectional Study

References

• World Health Organization. Global Tuberculosis Report 2021. World Health Organization; 2022.
   Google Scholar
• Cui EN, Yu T, Shang S-J, et al. Radiomics model for distinguishing tuberculosis and lung cancer on computed tomography scans. World J Clin Cases. 2020;8(21):5203–5212. doi:10.12998/wjcc.v8.i21.5203
   PubMed Web of Science ®Google Scholar
• Cheng SM, Zhou L, Zhou X. Expert consensus on diagnosis and prevention of inactive pulmonary tuberculosis. J Tuberc Lung Dis. 2021;2(03):197–201.
   Google Scholar
• Deng F, Lu XW. Expert consensus on the criteria for determining pulmonary tuberculosis activity and its clinical application. Chin J Anti Tuberc. 2020;42(04):301–307.
   Google Scholar
• Walter ND, Painter J, Parker M, et al. Persistent latent tuberculosis reactivation risk in United States immigrants. Am J Respir Crit Care Med. 2014;189(1):88–95. doi:10.1164/rccm.201308-1480OC
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang H, Xin H, et al. Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study. Eur Respir J. 2018;52(6):1801470. doi:10.1183/13993003.01470-2018
   PubMed Web of Science ®Google Scholar
• Yu Q, Yan J, Tian S, et al. A scoring system developed from a nomogram to differentiate active pulmonary tuberculosis from inactive pulmonary tuberculosis. Front Cell Infect Microbiol. 2022;12:947954. doi:10.3389/fcimb.2022.947954
   PubMed Web of Science ®Google Scholar
• Goldberg SV, Duchin JS, Shields T, Nolan CM. Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis. Am J Respir Crit Care Med. 1999;160(2):508–512. doi:10.1164/ajrccm.160.2.9808039
   PubMed Web of Science ®Google Scholar
• Mayito J, Meya DB, Rhein J, Sekaggya-Wiltshire C, Hasnain SE. Utility of the monocyte to lymphocyte ratio in diagnosing latent tuberculosis among HIV-infected individuals with a negative tuberculosis symptom screen. PLoS One. 2020;15(11):e0241786. doi:10.1371/journal.pone.0241786
   PubMed Web of Science ®Google Scholar
• Mendelson F, Griesel R, Tiffin N, et al. C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study. BMC Infect Dis. 2018;18(1):399. doi:10.1186/s12879-018-3303-6
   PubMedGoogle Scholar
• Ciccacci F, Floridia M, Bernardini R, et al. Plasma levels of CRP, neopterin and IP-10 in HIV-infected individuals with and without pulmonary tuberculosis. J Clin Tuberc Other Mycobact Dis. 2019;16:100107. doi:10.1016/j.jctube.2019.100107
   PubMedGoogle Scholar
• Meca AD, Turcu-Stiolica A, Bogdan M, et al. Screening performance of C-reactive protein for active pulmonary tuberculosis in HIV-positive patients: a systematic review with a meta-analysis. Front Immunol. 2022;13:891201. doi:10.3389/fimmu.2022.891201
   PubMed Web of Science ®Google Scholar
• Leboueny M, Siawaya ACM, Bouanga LDJ, et al. Changes of C-reactive protein and Procalcitonin after four weeks of treatment in patients with pulmonary TB. J Clin Tuberc Other Mycobact Dis. 2023;31:100348. doi:10.1016/j.jctube.2023.100348
   PubMedGoogle Scholar
• Ciccacci F, Welu B, Ndoi H. High-sensitivity C-reactive protein in HIV care: tuberculosis diagnosis and short-term mortality in a cohort of Kenyan HIV patients in the DREAM programme. Int J Infect Dis. 2021;104:329–334. doi:10.1016/j.ijid.2021.01.008
   PubMed Web of Science ®Google Scholar
• Caccamo N, Dieli F. Inflammation and the coagulation system in tuberculosis: tissue Factor leads the dance. Eur J Immunol. 2016;46(2):303–306. doi:10.1002/eji.201546225
   PubMed Web of Science ®Google Scholar
• Jin H. Effect of big data analysis-based remote management combined with yangyin runfei decoction on coagulation function, pulmonary function, and quality of life of pulmonary tuberculosis patients. Comput Intell Neurosci. 2022;2022:1708133. doi:10.1155/2022/1708133
   PubMed Web of Science ®Google Scholar
• Verma R, Mahapatro S, Kumar A, et al. Platelet dysfunction and coagulation assessment in patients of tuberculous meningitis. Neurol Sci. 2020;41(8):2103–2110. doi:10.1007/s10072-020-04299-4
   PubMed Web of Science ®Google Scholar
• Akpan PA, Akpotuzor JO, Osim EE. Haemostatic Indices as Markers for Monitoring Pulmonary Tuberculosis Treatment. Niger J Physiol Sci. 2018;33(1):31–35.
   PubMedGoogle Scholar
• de O Souza Filho JB, de Seixas JM, Galliez R, et al. A screening system for smear-negative pulmonary tuberculosis using artificial neural networks. Int J Infect Dis. 2016;49:33–39. doi:10.1016/j.ijid.2016.05.019
   PubMed Web of Science ®Google Scholar
• Yamada T, Haruki S, Minami Y, Numata M, Hagiwara N. The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure. J Cardiol. 2021;78(4):308–313. doi:10.1016/j.jjcc.2021.05.009
   PubMed Web of Science ®Google Scholar
• Maruyama S, Okamura A, Kanie Y, et al. C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients. Langenbecks Arch Surg. 2022;407(5):1901–1909. doi:10.1007/s00423-022-02508-6
   PubMed Web of Science ®Google Scholar
• Buttle TS, Hummerstone CY, Billahalli T, et al. The monocyte-to-lymphocyte ratio: sex-specific differences in the tuberculosis disease spectrum, diagnostic indices and defining normal ranges. PLoS One. 2021;16(8):e0247745. doi:10.1371/journal.pone.0247745
   PubMed Web of Science ®Google Scholar
• Gatechompol S, Sophonphan J, Kerr SJ, et al. Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV. Int J Tuberc Lung Dis. 2021;25(11):933–938. doi:10.5588/ijtld.21.0300
   PubMed Web of Science ®Google Scholar
• Sukson P, Liwsrisakun C, Inchai J, Trongtrakul K, Tajarernmuang P. Peripheral blood monocyte to lymphocyte ratio for prediction of tuberculous pleuritis. Int J Infect Dis. 2021;112:212–216. doi:10.1016/j.ijid.2021.09.033
   PubMed Web of Science ®Google Scholar
• Wang W, Du Z, Ni M, et al. Aspirin enhances the clinical efficacy of anti-tuberculosis therapy in pulmonary tuberculosis in patients with type 2 diabetes mellitus. Infect Dis. 2020;52(10):721–729. doi:10.1080/23744235.2020.1778177
   PubMed Web of Science ®Google Scholar
• Cudahy PGT, Warren JL, Cohen T, Wilson D. Trends in C-reactive protein, D-Dimer, and fibrinogen during therapy for HIV-associated multidrug-resistant tuberculosis. Am J Trop Med Hyg. 2018;99(5):1336–1341. doi:10.4269/ajtmh.18-0322
   PubMed Web of Science ®Google Scholar